Cognitive Insight in First-Episode Psychosis: Changes during Metacognitive Training.

cognitive insight experiment first-episode psychosis metacognitive training sessions

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
27 Nov 2020
Historique:
received: 22 10 2020
revised: 23 11 2020
accepted: 24 11 2020
entrez: 2 12 2020
pubmed: 3 12 2020
medline: 3 12 2020
Statut: epublish

Résumé

Metacognitive training (MCT) has demonstrated its efficacy in psychosis. However, the effect of each MCT session has not been studied. The aim of the study was to assess changes in cognitive insight after MCT: (a) between baseline, post-treatment, and follow-up; (b) after each session of the MCT controlled for intellectual quotient (IQ) and educational level. A total of 65 patients with first-episode psychosis were included in the MCT group from nine centers of Spain. Patients were assessed at baseline, post-treatment, and 6 months follow-up, as well as after each session of MCT with the Beck Cognitive Insight Scale (BCIS). The BCIS contains two subscales: self-reflectiveness and self-certainty, and the Composite Index. Statistical analysis was performed using linear mixed models with repeated measures at different time points. Self-certainty decreased significantly ( MCT intervention appears to have beneficial effects on cognitive insight by reducing self-certainty, especially after four sessions. Moreover, a minimum IQ is required to ensure benefits from MCT group intervention.

Sections du résumé

BACKGROUND BACKGROUND
Metacognitive training (MCT) has demonstrated its efficacy in psychosis. However, the effect of each MCT session has not been studied. The aim of the study was to assess changes in cognitive insight after MCT: (a) between baseline, post-treatment, and follow-up; (b) after each session of the MCT controlled for intellectual quotient (IQ) and educational level.
METHOD METHODS
A total of 65 patients with first-episode psychosis were included in the MCT group from nine centers of Spain. Patients were assessed at baseline, post-treatment, and 6 months follow-up, as well as after each session of MCT with the Beck Cognitive Insight Scale (BCIS). The BCIS contains two subscales: self-reflectiveness and self-certainty, and the Composite Index. Statistical analysis was performed using linear mixed models with repeated measures at different time points.
RESULTS RESULTS
Self-certainty decreased significantly (
CONCLUSIONS CONCLUSIONS
MCT intervention appears to have beneficial effects on cognitive insight by reducing self-certainty, especially after four sessions. Moreover, a minimum IQ is required to ensure benefits from MCT group intervention.

Identifiants

pubmed: 33260823
pii: jpm10040253
doi: 10.3390/jpm10040253
pmc: PMC7711871
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Instituto de Salud Carlos III
ID : PI11/01347 and PI14/00044

Références

Schizophr Res. 2018 Feb;192:281-286
pubmed: 28442249
BMC Psychiatry. 2017 Feb 6;17(1):54
pubmed: 28166760
Psychiatry Res. 2006 Jun 15;142(2-3):157-65
pubmed: 16631258
Schizophr Res Cogn. 2016 Sep 28;6:9-14
pubmed: 28740819
Schizophr Res. 2018 Nov;201:20-26
pubmed: 29903626
Br J Clin Psychol. 2013 Nov;52(4):408-23
pubmed: 24117913
Clin Psychol Rev. 2016 Jun;46:151-67
pubmed: 27216559
Eur Arch Psychiatry Clin Neurosci. 2018 Feb;268(1):57-64
pubmed: 28828697
Schizophr Res. 2004 Jun 1;68(2-3):319-29
pubmed: 15099613
Nord J Psychiatry. 2011 Jun;65(3):162-74
pubmed: 21563994
Schizophr Res. 2010 Aug;121(1-3):39-45
pubmed: 20399611
Schizophr Res. 2017 Jun;184:150-151
pubmed: 28069313
Clin Psychol Rev. 2017 Jul;55:12-24
pubmed: 28478270
Schizophr Bull. 2005 Jan;31(1):21-42
pubmed: 15888423
Psychiatry Res. 2014 Feb 28;215(2):308-13
pubmed: 24374116
World Psychiatry. 2018 Feb;17(1):12-23
pubmed: 29352540
Clin Psychol Rev. 2016 Dec;50:108-137
pubmed: 27771557
Schizophr Bull. 2010 Jul;36(4):830-5
pubmed: 19176474
Behav Res Ther. 2015 Jan;64:38-42
pubmed: 25513971
Schizophr Bull. 2018 Feb 15;44(2):307-316
pubmed: 29106693
World J Biol Psychiatry. 2014 Apr;15(3):219-28
pubmed: 22283467
Schizophr Res. 2007 Feb;90(1-3):325-33
pubmed: 17092694
Actas Esp Psiquiatr. 2012 Jan-Feb;40(1):2-9
pubmed: 22344490
Clin Psychol Rev. 2014 Jun;34(4):358-66
pubmed: 24866025
Schizophr Res Treatment. 2016;2016:6371856
pubmed: 27516906
J Psychiatr Ment Health Nurs. 2011 Sep;18(7):576-85
pubmed: 21848591
JAMA Psychiatry. 2014 Oct;71(10):1103-11
pubmed: 25103718
J Nerv Ment Dis. 2015 May;203(5):372-8
pubmed: 25900550
Br J Clin Psychol. 2009 Jun;48(Pt 2):141-62
pubmed: 19054432
J Nerv Ment Dis. 1992 Dec;180(12):773-80
pubmed: 1469376
Schizophr Bull. 2016 May;42(3):652-65
pubmed: 26519952
Schizophr Res. 2014 Jan;152(1):191-200
pubmed: 24355529
Psychol Med. 2017 Jul;47(9):1573-1584
pubmed: 28166848

Auteurs

Irene Birulés (I)

Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, 08830 Barcelona, Spain.
Department of Cognition, Development and Educational Psychology, Universitat de Barcelona, 08035 Barcelona, Spain.

Raquel López-Carrilero (R)

Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, 08830 Barcelona, Spain.
Investigación Biomédica en Red de Salud Mental (CIBERSAM) Instituto de Salud Carlos III C/Monforte de Lemos 3-5, Pabellón 11, Planta 0, 28029 Madrid, Spain.
Fundació Sant Joan de Déu, Esplugues de Llobregat, Santa Rosa, 39-57, 3a planta 08950 Esplugues de Llobregat, Barcelona, Spain.
Institut de Recerca en Salut Mental Sant Joan de Déu, Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, 08830 Barcelona, Spain.

Daniel Cuadras (D)

Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, 08830 Barcelona, Spain.
Fundació Sant Joan de Déu, Esplugues de Llobregat, Santa Rosa, 39-57, 3a planta 08950 Esplugues de Llobregat, Barcelona, Spain.

Esther Pousa (E)

Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Consorci Corporació Sanitària Parc Taulí de Sabadell, Parc Taulí, 1, 08208 Sabadell, Barcelona, Spain.

Maria Luisa Barrigón (ML)

Psychiatry Service, Area de Gestión Sanitaria Sur Granada, Motril, 18600 Granada, Spain.
Department of Psychiatry, IIS-Fundación Jiménez Díaz Hospital, 28040 Madrid, Spain.

Ana Barajas (A)

Centre d'Higiene Mental Les Corts, 08029 Barcelona, Spain.
Departament de Psicologia Clínica i de la Salut, Facultat de Psicologia, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.

Ester Lorente-Rovira (E)

Investigación Biomédica en Red de Salud Mental (CIBERSAM) Instituto de Salud Carlos III C/Monforte de Lemos 3-5, Pabellón 11, Planta 0, 28029 Madrid, Spain.
Psychiatry Service, Hospital Clínico Universitario de Valencia, 46010 Valencia, Spain.

Fermín González-Higueras (F)

UGC Salud Mental de Jaén, Servicio Andaluz de Salud, 23007 Jaen, Spain.

Eva Grasa (E)

Investigación Biomédica en Red de Salud Mental (CIBERSAM) Instituto de Salud Carlos III C/Monforte de Lemos 3-5, Pabellón 11, Planta 0, 28029 Madrid, Spain.
Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Institut d'Investigació Biomèdica-Sant Pau (IIB-Sant Pau), Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.

Isabel Ruiz-Delgado (I)

Unidad de Salud Mental Comunitaria Málaga Norte, UGC Salud Mental Carlos Haya, Servicio Andaluz de Salud Psychiatry Service, Antequera, 29200 Málaga, Spain.

Jordi Cid (J)

Mental Health & Addiction Research Group, IdiBGi, Institut d'Assistència Sanitària, 17190 Girona, Spain.

Ana de Apraiz (A)

Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, 08830 Barcelona, Spain.

Roger Montserrat (R)

Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, 08830 Barcelona, Spain.
Department of Cognition, Development and Educational Psychology, Universitat de Barcelona, 08035 Barcelona, Spain.

Trinidad Pélaez (T)

Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, 08830 Barcelona, Spain.
Investigación Biomédica en Red de Salud Mental (CIBERSAM) Instituto de Salud Carlos III C/Monforte de Lemos 3-5, Pabellón 11, Planta 0, 28029 Madrid, Spain.

Steffen Moritz (S)

Department of Psychiatry and Psychotherapy, University Medical Center Hamburg, 20251 Hamburg, Germany.
Sant Boi de Llobregat, 08830 Barcelona, Spain.

Susana Ochoa (S)

Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, 08830 Barcelona, Spain.
Investigación Biomédica en Red de Salud Mental (CIBERSAM) Instituto de Salud Carlos III C/Monforte de Lemos 3-5, Pabellón 11, Planta 0, 28029 Madrid, Spain.
Institut de Recerca en Salut Mental Sant Joan de Déu, Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, 08830 Barcelona, Spain.

Classifications MeSH